The King's Speech yesterday (which, for readers not in the UK, sets out the government's legislative plans) promises that the new Digital...

London's commercial real estate landscape is transforming, driven by the growing life sciences sector, which encompasses biotechnology,...

This article was first published in Kluwer Patent Blog [July, 2024]. Moderna secured a double victory in the Patents Court last week (2...

This article was first published in EPLAW Patent Blog, [July 2024]. On 2 July 2024, Mr Justice Meade handed down his decision in Moderna...

Last week, Adam Coughlin and Luca Cericola from Bristows’ Commercial IP team attended ON Helix 2024, an annual conference hosted by One...

“To ensure available lab space scales to meet the ambitions of our fast-growing research-intensive industries, not least the life...

If an AI system is classified as “high-risk”, the AI Act imposes significant requirements on the provider in order for it to place the...

This article was first published in Kluwer Patent Blog [July, 2024]. The recent rivaroxaban PI cases may have caused you to ask yourself...

This article was first published in Kluwer Patent Blog [June, 2024]. It has been about a year since the UPC issued its first PI decision,...

This article was first published in Kluwer Patent Blog [June, 2024]. Introduction On 19 June 2024, The Hague Local Division handed down a...

Introduction The NHS’ Health Research Authority (HRA) recently published its draft template Investigator Initiated Study Agreement (IIS...

It's hard to believe that six months have passed since we released the 11th edition of our Biotech Review of the Year publication. Our...